These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15122721

  • 1. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
    Metz LM, Zhang Y, Yeung M, Patry DG, Bell RB, Stoian CA, Yong VW, Patten SB, Duquette P, Antel JP, Mitchell JR.
    Ann Neurol; 2004 May; 55(5):756. PubMed ID: 15122721
    [No Abstract] [Full Text] [Related]

  • 2. Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
    Bonzano L, Roccatagliata L, Mancardi GL, Sormani MP.
    Mult Scler; 2009 Sep; 15(9):1043-7. PubMed ID: 19570818
    [Abstract] [Full Text] [Related]

  • 3. Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
    Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP.
    BMC Neurol; 2006 May 23; 6():19. PubMed ID: 16719908
    [Abstract] [Full Text] [Related]

  • 4. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
    Zhao Y, Traboulsee A, Petkau AJ, Li D.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1092-7. PubMed ID: 18003938
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging.
    Massacesi L, Parigi A, Barilaro A, Repice AM, Pellicanò G, Konze A, Siracusa G, Taiuti R, Amaducci L.
    Arch Neurol; 2005 Dec 25; 62(12):1843-7. PubMed ID: 16344342
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
    Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH.
    Ann Neurol; 2008 Mar 25; 63(3):395-400. PubMed ID: 18383069
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A, Alexander JS, Schwendimann RN, Kelley RE, Gonzalez-Toledo E, Jimenez JJ, Mauro L, Jy W, Smith SJ.
    Arch Neurol; 2008 Feb 25; 65(2):199-204. PubMed ID: 18071030
    [Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging as a surrogate for treatment effect on multiple sclerosis relapses.
    Arnold DL, Goodin DS.
    Ann Neurol; 2009 Mar 25; 65(3):237-8. PubMed ID: 19334057
    [No Abstract] [Full Text] [Related]

  • 9. The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study.
    Zabad RK, Metz LM, Todoruk TR, Zhang Y, Mitchell JR, Yeung M, Patry DG, Bell RB, Yong VW.
    Mult Scler; 2007 May 25; 13(4):517-26. PubMed ID: 17463074
    [Abstract] [Full Text] [Related]

  • 10. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
    Gauthier SA, Glanz BI, Mandel M, Tsagkaropoulos A, Neema M, Stankiewicz J, Arora A, Duan Y, Liptak Z, Egorova S, Buckle GJ, Bakshi R, Guttmann CR, Khoury SJ, Weiner HL.
    J Neurol Sci; 2009 Sep 15; 284(1-2):116-9. PubMed ID: 19428028
    [Abstract] [Full Text] [Related]

  • 11. Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy.
    Berger JR.
    Mult Scler; 2008 Jun 15; 14(5):708-10. PubMed ID: 18566035
    [Abstract] [Full Text] [Related]

  • 12. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
    Giacomini PS, Levesque IR, Ribeiro L, Narayanan S, Francis SJ, Pike GB, Arnold DL.
    Arch Neurol; 2009 Mar 15; 66(3):375-81. PubMed ID: 19273757
    [Abstract] [Full Text] [Related]

  • 13. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
    Río J, Rovira A, Tintoré M, Huerga E, Nos C, Tellez N, Tur C, Comabella M, Montalban X.
    Mult Scler; 2008 May 15; 14(4):479-84. PubMed ID: 18562504
    [Abstract] [Full Text] [Related]

  • 14. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC.
    Neurology; 2009 Feb 24; 72(8):705-11. PubMed ID: 19073945
    [Abstract] [Full Text] [Related]

  • 15. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M.
    J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621
    [Abstract] [Full Text] [Related]

  • 16. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O.
    Arch Neurol; 2009 May 30; 66(5):593-9. PubMed ID: 19433659
    [Abstract] [Full Text] [Related]

  • 17. No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen N.
    Neurology; 2009 Feb 24; 72(8):686-7. PubMed ID: 19237696
    [No Abstract] [Full Text] [Related]

  • 18. Short-term combination of glatiramer acetate with i.v. steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis.
    De Stefano N, Filippi M, Hawkins C, 9011 study group.
    J Neurol Sci; 2008 Mar 15; 266(1-2):44-50. PubMed ID: 17897678
    [Abstract] [Full Text] [Related]

  • 19. Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
    Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I.
    Lancet; 2004 May 15; 363(9421):1607-8. PubMed ID: 15145635
    [Abstract] [Full Text] [Related]

  • 20. Clinical-radiologic heterogeneity of occipital neuralgiform pain as multiple sclerosis relapse.
    De Santi L, Monti L, Menci E, Bellini M, Annunziata P.
    Headache; 2009 Feb 15; 49(2):304-7. PubMed ID: 18647183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.